PTHS Pelthos Therapeutics Inc.
Healthcare · Market cap: $28.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $100.0K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $25.8K | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $280.3K |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $999.8K | $105.1K |
| 2026-Q3 | $0 | $55.9K |
| 2026-Q4 | $0 | $44.9K |
Bought$1.1M7 buy days
Sold$486.3K13 sell days
Net insider flow+$639.3Knet buying · 5 years
Latest trade2026-10-02Greenleaf Peter
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-10-02 | Sell | Greenleaf Peter | Director | 797 | $21.17 | $16.9K | 1 |
| 2026-10-02 | Sell | Pauls Matthew | Director | 786 | $21.00 | $16.5K | 1 |
| 2026-10-02 | Sell | Friedberg Ezra M | Director | 558 | $20.72 | $11.6K | 1 |
| 2026-07-02 | Sell | Greenleaf Peter | Director | 797 | $26.13 | $20.8K | 2 |
| 2026-07-02 | Sell | Pauls Matthew | Director | 786 | $26.16 | $20.6K | 2 |
| 2026-07-02 | Sell | Friedberg Ezra M | Director | 558 | $26.09 | $14.6K | 2 |
| 2026-06-15 | Sell | Friedberg Ezra M | Director | 283 | $27.29 | $7.7K | 2 |
| 2026-06-11 | Buy | Davis Todd C | Director | 35,948 | $27.81 | $999.8K | 2 |
| 2026-05-22 | Sell | Francis Knuettel II | CFO | 1,500 | $26.84 | $40.3K | 1 |
| 2026-04-02 | Sell | Greenleaf Peter | Director | 797 | $20.92 | $16.7K | 2 |
| 2026-04-02 | Sell | Pauls Matthew | Director | 786 | $20.92 | $16.4K | 2 |
| 2026-04-02 | Sell | Malamut Richard | Director | 590 | $20.91 | $12.3K | 2 |
| 2026-04-02 | Sell | Friedberg Ezra M | Director | 558 | $20.91 | $11.7K | 2 |
| 2025-11-25 | Sell | Friedberg Ezra M | Director | 10,000 | $28.03 | $280.3K | 4 |
| 2024-09-13 | Buy | Francis Knuettel II | CEO | 3,500 | $0.97 | $3.4K | 1 |
| 2024-09-12 | Buy | Malamut Richard | Director | 10,400 | $0.94 | $9.8K | 1 |
| 2024-09-12 | Buy | Francis Knuettel II | CEO | 1,700 | $0.97 | $1.6K | 1 |
| 2024-09-11 | Buy | Francis Knuettel II | CEO | 5,500 | $0.94 | $5.2K | 1 |
| 2024-09-10 | Buy | Francis Knuettel II | CEO | 6,500 | $0.89 | $5.8K | 1 |
| 2024-02-21 | Buy | Friedberg Ezra M | Director | 16,667 | $6.00 | $100.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Davis Todd C | Director | $999.8K | $0 | 2026-06-11 |
| Friedberg Ezra M | Director | $100.0K | $325.8K | 2026-10-02 |
| Francis Knuettel II | CFO | $16.0K | $40.3K | 2026-05-22 |
| Greenleaf Peter | Director | $0 | $54.4K | 2026-10-02 |
| Pauls Matthew | Director | $0 | $53.5K | 2026-10-02 |
| Malamut Richard | Director | $9.8K | $12.3K | 2026-04-02 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.